BIO-TECHNE Corp — Director's Dealing 2016

Aug 22, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2016-08-18

Reporting Person: Eansor Norman David (SVP - Biotech)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-08-18	Stock Option (Right to Buy)	$106.59	A	18819	Acquired	2023-08-18	Common Stock (18819)	Direct
2016-08-18	Stock Option (Right to Buy)	$106.59	A	14114	Acquired	2023-08-18	Common Stock (14114)	Direct
2016-08-18	Restricted Stock Units	$	A	2287	Acquired		Common Stock (2287)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	3936	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$94.35	2021-08-12	Common Stock (15000)	15000	Direct
Stock Option (Right to Buy)	$108.49	2022-08-07	Common Stock (12500)	12500	Direct
Stock Option (Right to Buy)	$108.49	2022-08-07	Common Stock (9375)	9375	Direct
Restricted Stock Units	$		Common Stock (1500)	1500	Direct

Footnotes

F1: Includes 1,666 shares of restricted stock units that vest on 7/1/17.

F2: 3,750 shares vest on each of 8/12/15, 8/12/16, 8/12/17 and 8/12/18.

F3: 3,125 shares vest on each of 8/7/16, 8/7/17, 8/7/18 and 8/7/19.

F4: Vests in full or in part on 8/7/18 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

F5: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.

F6: Vests 4,705 shares on each of 8/18/17, 8/18/18, and 8/18/19 and 4,704 shares on 8/18/20.

F7: Vests in full or in part on 8/18/19 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).